Translational physiology: Porcine models of human coronary artery disease: Implications for preclinical trials of therapeutic angiogenesis

G. Chad Hughes, Mark J. Post, Michael Simons, Brian H. Annex

Research output: Contribution to journalReview article

Abstract

"Therapeutic angiogenesis" describes an emerging field of cardiovascular medicine whereby new blood vessels are induced to grow to supply oxygen and nutrients to ischemic cardiac or skeletal muscle. Various methods of producing therapeutic angiogenesis have been employed, including mechanical means, gene therapy, and the use of growth factors, among others. The use of appropriate large-animal models is essential if these therapies are to be critically evaluated in a preclinical setting before their use in humans, yet little has been written comparing the various available models. Over the past decade, swine have been increasingly used in studies of chronic ischemia because of their numerous similarities to humans, including minimal preexisting coronary collaterals as well as similar coronary anatomy and physiology. Consequently, this review describes the most commonly used swine models of chronic myocardial ischemia with special attention to regional myocardial blood flow and function and critically evaluates the strengths and weaknesses of each model in terms of utility for preclinical trials of angiogenic therapies.

Original languageEnglish (US)
Pages (from-to)1689-1701
Number of pages13
JournalJournal of Applied Physiology
Volume94
Issue number5
DOIs
StatePublished - May 1 2003
Externally publishedYes

Fingerprint

Coronary Artery Disease
Swine
Regional Blood Flow
Therapeutics
Genetic Therapy
Myocardial Ischemia
Blood Vessels
Anatomy
Intercellular Signaling Peptides and Proteins
Myocardium
Skeletal Muscle
Ischemia
Animal Models
Medicine
Oxygen
Food

Keywords

  • Animal models
  • Coronary disease
  • Hibernation
  • Myocardial ischemia

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Translational physiology : Porcine models of human coronary artery disease: Implications for preclinical trials of therapeutic angiogenesis. / Hughes, G. Chad; Post, Mark J.; Simons, Michael; Annex, Brian H.

In: Journal of Applied Physiology, Vol. 94, No. 5, 01.05.2003, p. 1689-1701.

Research output: Contribution to journalReview article

Hughes, G. Chad ; Post, Mark J. ; Simons, Michael ; Annex, Brian H. / Translational physiology : Porcine models of human coronary artery disease: Implications for preclinical trials of therapeutic angiogenesis. In: Journal of Applied Physiology. 2003 ; Vol. 94, No. 5. pp. 1689-1701.
@article{9818263d60184d638e52529aa951822c,
title = "Translational physiology: Porcine models of human coronary artery disease: Implications for preclinical trials of therapeutic angiogenesis",
abstract = "{"}Therapeutic angiogenesis{"} describes an emerging field of cardiovascular medicine whereby new blood vessels are induced to grow to supply oxygen and nutrients to ischemic cardiac or skeletal muscle. Various methods of producing therapeutic angiogenesis have been employed, including mechanical means, gene therapy, and the use of growth factors, among others. The use of appropriate large-animal models is essential if these therapies are to be critically evaluated in a preclinical setting before their use in humans, yet little has been written comparing the various available models. Over the past decade, swine have been increasingly used in studies of chronic ischemia because of their numerous similarities to humans, including minimal preexisting coronary collaterals as well as similar coronary anatomy and physiology. Consequently, this review describes the most commonly used swine models of chronic myocardial ischemia with special attention to regional myocardial blood flow and function and critically evaluates the strengths and weaknesses of each model in terms of utility for preclinical trials of angiogenic therapies.",
keywords = "Animal models, Coronary disease, Hibernation, Myocardial ischemia",
author = "Hughes, {G. Chad} and Post, {Mark J.} and Michael Simons and Annex, {Brian H.}",
year = "2003",
month = "5",
day = "1",
doi = "10.1152/japplphysiol.00465.2002",
language = "English (US)",
volume = "94",
pages = "1689--1701",
journal = "Journal of Applied Physiology Respiratory Environmental and Exercise Physiology",
issn = "8750-7587",
publisher = "American Physiological Society",
number = "5",

}

TY - JOUR

T1 - Translational physiology

T2 - Porcine models of human coronary artery disease: Implications for preclinical trials of therapeutic angiogenesis

AU - Hughes, G. Chad

AU - Post, Mark J.

AU - Simons, Michael

AU - Annex, Brian H.

PY - 2003/5/1

Y1 - 2003/5/1

N2 - "Therapeutic angiogenesis" describes an emerging field of cardiovascular medicine whereby new blood vessels are induced to grow to supply oxygen and nutrients to ischemic cardiac or skeletal muscle. Various methods of producing therapeutic angiogenesis have been employed, including mechanical means, gene therapy, and the use of growth factors, among others. The use of appropriate large-animal models is essential if these therapies are to be critically evaluated in a preclinical setting before their use in humans, yet little has been written comparing the various available models. Over the past decade, swine have been increasingly used in studies of chronic ischemia because of their numerous similarities to humans, including minimal preexisting coronary collaterals as well as similar coronary anatomy and physiology. Consequently, this review describes the most commonly used swine models of chronic myocardial ischemia with special attention to regional myocardial blood flow and function and critically evaluates the strengths and weaknesses of each model in terms of utility for preclinical trials of angiogenic therapies.

AB - "Therapeutic angiogenesis" describes an emerging field of cardiovascular medicine whereby new blood vessels are induced to grow to supply oxygen and nutrients to ischemic cardiac or skeletal muscle. Various methods of producing therapeutic angiogenesis have been employed, including mechanical means, gene therapy, and the use of growth factors, among others. The use of appropriate large-animal models is essential if these therapies are to be critically evaluated in a preclinical setting before their use in humans, yet little has been written comparing the various available models. Over the past decade, swine have been increasingly used in studies of chronic ischemia because of their numerous similarities to humans, including minimal preexisting coronary collaterals as well as similar coronary anatomy and physiology. Consequently, this review describes the most commonly used swine models of chronic myocardial ischemia with special attention to regional myocardial blood flow and function and critically evaluates the strengths and weaknesses of each model in terms of utility for preclinical trials of angiogenic therapies.

KW - Animal models

KW - Coronary disease

KW - Hibernation

KW - Myocardial ischemia

UR - http://www.scopus.com/inward/record.url?scp=0037404439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037404439&partnerID=8YFLogxK

U2 - 10.1152/japplphysiol.00465.2002

DO - 10.1152/japplphysiol.00465.2002

M3 - Review article

C2 - 12679343

AN - SCOPUS:0037404439

VL - 94

SP - 1689

EP - 1701

JO - Journal of Applied Physiology Respiratory Environmental and Exercise Physiology

JF - Journal of Applied Physiology Respiratory Environmental and Exercise Physiology

SN - 8750-7587

IS - 5

ER -